Author:
Li Xiaoying,Shao Minhua,Wang Shiming,Zhao Xueying,Chen Hongyan,Qian Ji,Song Xiao,Wang Jiucun,Jin Li,Wu Junjie,Li Qiang,Bai Chunxue,Han Baohui,Gao Zhiqiang,Lu Daru
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. doi: 10.3322/caac.20107 .
2. Zhao X, Wang X, Wu W, Gao Z, Wu J, Garfield DH, et al. Matrix metalloproteinase-2 polymorphisms and clinical outcome of Chinese patients with nonsmall cell lung cancer treated with first-line, platinum-based chemotherapy. Cancer. 2012;118(14):3587–98. doi: 10.1002/cncr.26669 .
3. Wang L, Liao ML, Li LY, Wan HY, Xu N, Liu JW, et al. Clinical benefit of gemcitabine plus cisplatin 3-week regimen for patients with advanced non-small cell lung cancer: a prospective observational study. Chin Med J (Engl). 2004;117(11):1607–10.
4. Han B, Gao G, Wu W, Gao Z, Zhao X, Li L, et al. Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients. Lung Cancer. 2011;72(2):238–43. doi: 10.1016/j.lungcan.2010.09.001 .
5. Shiraishi K, Kohno T, Tanai C, Goto Y, Kuchiba A, Yamamoto S, et al. Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer. J Clin Oncol. 2010;28(33):4945–52. doi: 10.1200/JCO.2010.30.5334 .
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献